Automated glucose control systems in post-pancreatectomy diabetes: systematic review of clinical efficacy and nursing care implications.
Chiara G Alaimo, Filippo Bianchi, Stefano Mancin et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review assessed automated or semi-automated glucose control in adults with diabetes after pancreatic resection for malignancy. Four studies—three randomized trials and one prospective time-motion simulation—included 66 participants. Fully closed-loop systems increased time in range to 77.7±4.6% versus 41.1±19.5% with standard care and virtually eliminated severe hypoglycemia. A bihormonal artificial pancreas also improved euglycemia and reduced time below range to 0%. Evidence certainty ranged from very low for continuous glucose metrics to moderate for prevention of severe hypoglycemia.
Key findings
- Fully closed-loop systems achieved time in range of 77.7±4.6% versus 41.1±19.5% with standard care.
- Fully closed-loop systems virtually eliminated severe hypoglycemia; certainty for this outcome was moderate.
- A bihormonal artificial pancreas increased euglycemia from 54% to 78% and reduced time below range to 0%.
- A time-motion simulation estimated a 67% reduction in nursing workload for major surgery.
Why it matters
Diabetes after pancreatic resection can involve marked glucose variability and severe hypoglycemia. The review suggests automated systems may improve perioperative glycemic stability, while the simulation indicates potential to reduce nursing workload. However, evidence certainty varies by outcome, and the small evidence base means these findings should be interpreted cautiously.
What to keep in mind
Only four studies with 66 participants were included. Certainty was very low for continuous glucose metrics, and the authors call for larger multicenter studies with longer follow-up.